BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 36307864)

  • 1. RAB4A GTPase regulates epithelial-to-mesenchymal transition by modulating RAC1 activation.
    Karthikeyan S; Casey PJ; Wang M
    Breast Cancer Res; 2022 Oct; 24(1):72. PubMed ID: 36307864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of Rac1 Pathway in Epithelial-to-Mesenchymal Transition and Cancer Stem-like Cell Phenotypes in Gastric Adenocarcinoma.
    Yoon C; Cho SJ; Chang KK; Park DJ; Ryeom SW; Yoon SS
    Mol Cancer Res; 2017 Aug; 15(8):1106-1116. PubMed ID: 28461325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NKCC1 promotes EMT-like process in GBM via RhoA and Rac1 signaling pathways.
    Ma H; Li T; Tao Z; Hai L; Tong L; Yi L; Abeysekera IR; Liu P; Xie Y; Li J; Yuan F; Zhang C; Yang Y; Ming H; Yu S; Yang X
    J Cell Physiol; 2019 Feb; 234(2):1630-1642. PubMed ID: 30159893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epithelial-mesenchymal transition of ovarian cancer cells is sustained by Rac1 through simultaneous activation of MEK1/2 and Src signaling pathways.
    Fang D; Chen H; Zhu JY; Wang W; Teng Y; Ding HF; Jing Q; Su SB; Huang S
    Oncogene; 2017 Mar; 36(11):1546-1558. PubMed ID: 27617576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Knockdown on aPKC-ι inhibits epithelial-mesenchymal transition, migration and invasion of colorectal cancer cells through Rac1-JNK pathway.
    Du GS; Qiu Y; Wang WS; Peng K; Zhang ZC; Li XS; Xiao WD; Yang H
    Exp Mol Pathol; 2019 Apr; 107():57-67. PubMed ID: 30465755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IBP regulates epithelial-to-mesenchymal transition and the motility of breast cancer cells via Rac1, RhoA and Cdc42 signaling pathways.
    Zhang Z; Yang M; Chen R; Su W; Li P; Chen S; Chen Z; Chen A; Li S; Hu C
    Oncogene; 2014 Jun; 33(26):3374-82. PubMed ID: 23975422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ERK2 regulates epithelial-to-mesenchymal plasticity through DOCK10-dependent Rac1/FoxO1 activation.
    Shin S; Buel GR; Nagiec MJ; Han MJ; Roux PP; Blenis J; Yoon SO
    Proc Natl Acad Sci U S A; 2019 Feb; 116(8):2967-2976. PubMed ID: 30728292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tight junction protein cingulin variant is associated with cancer susceptibility by overexpressed IQGAP1 and Rac1-dependent epithelial-mesenchymal transition.
    Huang YT; Hsu YT; Wu PY; Yeh YM; Lin PC; Hsu KF; Shen MR
    J Exp Clin Cancer Res; 2024 Mar; 43(1):65. PubMed ID: 38424547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetically upregulated GEFT-derived invasion and metastasis of rhabdomyosarcoma via epithelial mesenchymal transition promoted by the Rac1/Cdc42-PAK signalling pathway.
    Liu C; Zhang L; Cui W; Du J; Li Z; Pang Y; Liu Q; Shang H; Meng L; Li W; Song L; Wang P; Xie Y; Wang Y; Liu Y; Hu J; Zhang W; Li F
    EBioMedicine; 2019 Dec; 50():122-134. PubMed ID: 31761617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different signaling and functionality of Rac1 and Rac1b in the progression of lung adenocarcinoma.
    Seiz JR; Klinke J; Scharlibbe L; Lohfink D; Heipel M; Ungefroren H; Giehl K; Menke A
    Biol Chem; 2020 Mar; 401(4):517-531. PubMed ID: 31811797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bmi1 regulates self-renewal and epithelial to mesenchymal transition in breast cancer cells through Nanog.
    Paranjape AN; Balaji SA; Mandal T; Krushik EV; Nagaraj P; Mukherjee G; Rangarajan A
    BMC Cancer; 2014 Oct; 14():785. PubMed ID: 25348805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tiam1 promotes thyroid carcinoma metastasis by modulating EMT via Wnt/β-catenin signaling.
    Liu L; Wu B; Cai H; Li D; Ma Y; Zhu X; Lv Z; Fan Y; Zhang X
    Exp Cell Res; 2018 Jan; 362(2):532-540. PubMed ID: 29277502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RAC1B: A Guardian of the Epithelial Phenotype and Protector Against Epithelial-Mesenchymal Transition.
    Zinn R; Otterbein H; Lehnert H; Ungefroren H
    Cells; 2019 Dec; 8(12):. PubMed ID: 31817229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CSRP2 suppresses colorectal cancer progression
    Chen L; Long X; Duan S; Liu X; Chen J; Lan J; Liu X; Huang W; Geng J; Zhou J
    Theranostics; 2020; 10(24):11063-11079. PubMed ID: 33042270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. POTEE promotes breast cancer cell malignancy by inducing invadopodia formation through the activation of SUMOylated Rac1.
    Martínez-López A; García-Casas A; Infante G; González-Fernández M; Salvador N; Lorente M; Mendiburu-Eliçabe M; Gonzalez-Moreno S; Villarejo-Campos P; Velasco G; Malliri A; Castillo-Lluva S
    Mol Oncol; 2024 Mar; 18(3):620-640. PubMed ID: 38098337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. mTOR regulate EMT through RhoA and Rac1 pathway in prostate cancer.
    Chen X; Cheng H; Pan T; Liu Y; Su Y; Ren C; Huang D; Zha X; Liang C
    Mol Carcinog; 2015 Oct; 54(10):1086-95. PubMed ID: 25043657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a GαGβγ, AKT and PKCα signalome associated with invasive growth in two genetic models of human breast cancer cell epithelial-to-mesenchymal transition.
    Ouelaa-Benslama R; De Wever O; Hendrix A; Sabbah M; Lambein K; Land D; Prévost G; Bracke M; Hung MC; Larsen AK; Emami S; Gespach C
    Int J Oncol; 2012 Jul; 41(1):189-200. PubMed ID: 22552300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Notch1 signaling regulates the epithelial-mesenchymal transition and invasion of breast cancer in a Slug-dependent manner.
    Shao S; Zhao X; Zhang X; Luo M; Zuo X; Huang S; Wang Y; Gu S; Zhao X
    Mol Cancer; 2015 Feb; 14(1):28. PubMed ID: 25645291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. mTORC1 and mTORC2 regulate EMT, motility, and metastasis of colorectal cancer via RhoA and Rac1 signaling pathways.
    Gulhati P; Bowen KA; Liu J; Stevens PD; Rychahou PG; Chen M; Lee EY; Weiss HL; O'Connor KL; Gao T; Evers BM
    Cancer Res; 2011 May; 71(9):3246-56. PubMed ID: 21430067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of chemotherapy-related breast tumor EMT by application of redox-sensitive siRNA delivery system CSO-ss-SA/siRNA along with doxorubicin treatment.
    Liu X; Zhou XQ; Shang XW; Wang L; Li Y; Yuan H; Hu FQ
    J Zhejiang Univ Sci B; 2020 Mar; 21(3):218-233. PubMed ID: 32133799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.